Source: Zhizhen Health; Editor: Bai XiaofeiReprint Requirements: Can be reprinted 24 hours after the first publication, source must be credited.
Recently, it has been praised as"The Oscar of the design world" - the American MUSE Design Awards(MUSE Design Awards) Announces 2024 Annual Results.Zhizhen HealthSelf-developed Products"AI Fundus Camera"Breaking through the circle of influence from tens of thousands of entries across 108 countries and regions globally,Wins Silver Award for Product Design - Medical Devices。The Self-developed Product "AI Fundus Camera" That Won This AwardOnce obtained FDA certification in the United States and CE certification in the European Union.。American MUSE Design AwardIt's Zhizhen Health AI Fundus CameraFollowing the wins of the German Red Dot and the American IDA Design Awards,The Third Renowned International Design Award. This is not only a recognition of Zhizhen Health's humanized and innovative design philosophy, but also an affirmation of Zhizhen Health's product innovation capabilities.
MUSE Design Awards (Muse International Design Awards) is hosted by the American Alliance of Museums (AAM) and the International Awards Association (IAA).One of the most influential international awards in the global creative field。
The award is evaluated once a year, gathering global cross-disciplinary design thinking, and is known for its strict evaluation system and high-quality judging criteria. Its mission is not only to recognize and promote the winning works but also to enhance global creative standards and stimulate continuous innovation in design and creative fields.Referred to as the "Oscar" of American design by designers。
"Expert Consensus on Community Screening for Diabetic Retinopathy" points out: Artificial intelligence (AI) promotes DR (Digital RadiographyFundus Image Screening,AI Automated DR Detection System Based on Deep Learning Algorithm Exhibits High Sensitivity and Specificity in DR Fundus ImagesThe development and application of AI technology can help alleviate current medical pain points, optimize medical resources, reduce screening costs, and provide new ideas for DR screening work.▲ Source: Company official websiteThe award-winning "AI Fundus Camera" is a fundus camera that combines lightness, portability, and practicality.Ergonomically designed for comfortable handling, can be easily held with one hand.. At the same time, the appearance is simple,Portable and desktop switchable, suitable for rapid screening in various clinical and off-site professional service scenarios.Zhizhen Health "AI Fundus Camera"Jointly created by Zhizhen Health and the birthplace of Chinese optics — Changchun University of Science and TechnologyThe optical core part was led by Professor Wang Xiantao, with the optical design team from scientific research institutions such as Shanghai Institute of Optics and Fine Mechanics, Changchun Institute of Optics, Fine Mechanics and Physics, and Changchun University of Science and Technology, and was jointly completed with Zhizhen Health, possessing full independent intellectual property rights.Ophthalmic Camera with Integrated AI, Optics, Mechanics, Electronics, and Computing, with core technology leading advantages both in China and internationally.The AI fundus camera of the company is equipped with various artificial intelligence technologies. The device hasIntelligent Optoelectronic Imaging, Wide-angle High-definition Non-invasive Photography, Clinical Intelligent Auxiliary DiagnosisThree core advantages make it convenient for rapid screening in clinical and out-of-hospital professional service scenarios such as physical examination centers, endocrinology departments, geriatrics departments, elderly care stations, nursing homes, pharmacies, and health kiosks, as well as for examining elderly and mobility-impaired patients. It can address many challenges of traditional screening models, enabling efficient and high-quality screening.EyePreviously,The device has been approved.NMPA Class II Medical Device Registration Certificate, and at the same time also obtainedFDA、CEInternational certifications。
▲ Source: National Medical Products Administration
The cameraCan perform quantitative analysis on fundus images taken at different times., such as changes in lesions, changes in the optic disc, and changes in blood vessels, accurately compare the changes in the patient's fundus status.Can effectively identify high-risk groups for fundus lesions such as diabetes and hypertension., The early lesions of these diseases will be reflected on the retina.
▲ Source: Company's official website
The camera allows more patients to enjoy inclusiveScreening effectively strengthens the management of fundus complications, reduces the risk of blindness caused by various diseases, and improves patients' quality of life.With leading AI algorithms and products, Zhizhen HealthClinical service capabilities have been successfully integrated with leading hospitals both in China and abroad., has been used in top-tier hospitals such as Peking Union Medical College Hospital, Chinese PLA General Hospital (301), and Sichuan Provincial People's Hospital, accumulating rich service experience and capabilities in clinical aspects. Currently,Zhizhen Health's products have a market share of over 50% in China's top 100 tertiary hospitals, covering 26 provinces and regions across the country.。
Beijing Zhizhen Health Technology Co., Ltd.(ZHENHEALTH®️) was established in Haidian, Beijing in 2015, and is committed to providing high-quality services/products for the medical and health industry.AI Health Management Solutions。
The core team comes from top global academic research institutions and Fortune 500 high-tech companies. With years of deep accumulation in technologies such as artificial intelligence, cloud computing, and big data, as well as a new operational model for health management, they efficiently integrate high-quality medical service resources both in China and internationally.Realize the interconnection of users, pharmaceutical services and clinical technology。
Zhizhen Health's services focus onEarly Screening, Quantitative Assessment, and Auxiliary Diagnosis for National Health. The R&D production line covers the needs of health management throughout the entire human life cycle,A number of self-developed software and hardware products have obtained Class III and Class II medical device registration certificates issued by the China Food and Drug Administration., with nearly a hundred global patents, has completed medical device approvals from the US FDA and EU CE.
As of the date of publication, the company's financing history is as follows:
